Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioceres Crop Solutions (BIOX) EPS (Weighted Average and Diluted) (2021 - 2026)

Bioceres Crop Solutions' EPS (Weighted Average and Diluted) history spans 4 years, with the latest figure at -$0.14 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 441.8% to -$0.14 in Q1 2026 year-over-year; TTM through Mar 2026 was -$0.14, a 441.8% decrease, with the full-year FY2025 number at -$0.88, down 1402.23% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.14 in Q1 2026 for Bioceres Crop Solutions, down from $0.04 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for BIOX hit a ceiling of $0.04 in Q1 2025 and a floor of -$0.14 in Q1 2026.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.05 across 3 years, with a median of -$0.05 in 2022.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 150.0% in 2022 and later tumbled 441.8% in 2026.
  • Tracing BIOX's EPS (Weighted Average and Diluted) over 3 years: stood at -$0.05 in 2022, then surged by 182.8% to $0.04 in 2025, then plummeted by 441.8% to -$0.14 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for BIOX at -$0.14 in Q1 2026, $0.04 in Q1 2025, and -$0.05 in Q2 2022.